A randomized phase II study evaluating different maintenance schedules of nab-paclitaxel in the first-line treatment of metastatic breast cancer: Final results of the IBCSG 42-12/BIG 2-12 SNAP trial

  1. Gennari, A.
  2. Sun, Z.
  3. Hasler-Strub, U.
  4. Colleoni, M.
  5. Kennedy, M.J.
  6. Von Moos, R.
  7. Cortés, J.
  8. Vidal, M.J.
  9. Hennessy, B.
  10. Walshe, J.
  11. Amillano Parraga, K.
  12. Ribi, K.
  13. Bernhard, J.
  14. Morales Murillo, S.
  15. Pagani, O.
  16. Barbeaux, A.
  17. Borstnar, S.
  18. Rabaglio-Poretti, M.
  19. Maibach, R.
  20. Regan, M.M.
  21. Jerusalem, G.
Journal:
Annals of Oncology

ISSN: 1569-8041,  0923-7534

Year of publication: 2018

Volume: 29

Issue: 3

Pages: 661-668

Type: Article

DOI: 10.1093/ANNONC/MDX772 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus